12 May 2021 - Fast track designation highlights the urgent need for improved intra-operative nerve identification. ...
6 May 2021 - FDA breakthrough designation validates Viome's proprietary mRNA analysing technology and state of the art AI platform to ...
4 May 2021 - Oculogica's EyeBOX is the only objective diagnostic cleared by the US FDA and Australia TGA as an ...
26 April 2021 - Half of the more than 550,000 Australians expected to die from cancer in the next decade could ...
23 April 2021 - VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the ...
19 April 2021 - Half of all patients with non-small cell lung cancer have oncogene mutations, yet many patients are not ...
20 April 2021 - First US FDA oncology assay submission for Biocartis. ...
14 April 2021 - Telix is pleased to announce that the TGA has accepted the Company’s submission for the registration ...
31 March 2021 - Desperate cancer patients are begging Australia’s drugs regulator to save lives by speeding up approvals and cutting ...
26 March 2021 - Amazon on Friday received emergency use authorisation from the FDA for an at-home COVID-19 testing kit that ...
24 March 2021 - The direct to consumer test is now authorised by the FDA to sell directly to consumers online ...
22 March 2021 - New partnerships make same-day delivery of FDA authorised COVID-19 test collection kits widely available to consumers across ...
17 March 2021 - BioFire Respiratory Panel 2.1 is the first COVID-19 diagnostic test granted marketing authorisation using the de novo ...
15 March 2021 - The Oncotype DX Breast Recurrence Score Test now able to be funded via 6 to 24 month ...
9 March 2021 - The Ventana ALK (D5F3) CDx Assay is now FDA approved as a companion diagnostic in four targeted ...